SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 110 filers reported holding SUTRO BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 1.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $237,084 | -9.8% | 68,324 | +20.9% | 0.00% | 0.0% |
| Q2 2023 | $262,837 | +24.1% | 56,524 | +23.3% | 0.00% | 0.0% |
| Q1 2023 | $211,845 | -58.5% | 45,854 | -27.4% | 0.00% | -50.0% |
| Q4 2022 | $510,042 | +33.9% | 63,124 | -8.1% | 0.00% | 0.0% |
| Q3 2022 | $381,000 | +6.4% | 68,684 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $358,000 | +6.2% | 68,684 | +67.5% | 0.00% | +100.0% |
| Q1 2022 | $337,000 | -44.8% | 41,004 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $610,000 | -21.3% | 41,004 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $775,000 | -4.7% | 41,004 | -6.3% | 0.00% | 0.0% |
| Q2 2021 | $813,000 | +172.8% | 43,754 | +47.6% | 0.00% | +300.0% |
| Q3 2020 | $298,000 | +61.1% | 29,641 | +24.3% | 0.00% | 0.0% |
| Q2 2020 | $185,000 | – | 23,854 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,824,542 | $34,466,000 | 16.86% |
| Samsara BioCapital, LLC | 1,675,579 | $31,652,000 | 4.97% |
| First Light Asset Management, LLC | 2,191,439 | $41,396,000 | 2.73% |
| FRAZIER MANAGEMENT LLC | 1,468,663 | $27,743,000 | 2.22% |
| AJU IB Investment Co., Ltd. | 175,000 | $3,306,000 | 2.13% |
| Opaleye Management Inc. | 537,800 | $10,159,000 | 1.90% |
| Parkman Healthcare Partners LLC | 163,389 | $3,086,000 | 0.78% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,233,695 | $42,194,000 | 0.71% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 139,331 | $2,629,000 | 0.63% |
| BVF INC/IL | 826,825 | $15,619,000 | 0.61% |